Behavioral, Virologic, and Immunologic Factors Associated With Acquisition and Severity of Primary Epstein–Barr Virus Infection in University Students
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
BACKGROUND: University students were studied prospectively to determine the incidence of and risk factors for acquisition of primary Epstein-Barr virus (EBV) infection and the virologic and immune correlates of disease severity. METHODS: EBV antibody-negative freshmen participated in monthly surveillance until graduation. If antibodies developed, proximate samples were assayed for viral load by polymerase chain reaction. Lymphocyte and natural killer (NK) cell numbers and activation were measured by flow cytometry, and plasma cytokine levels were measured by a multiplex assay. RESULTS: Of 546 students screened, 202 (37%) were antibody negative; 143 antibody-negative students were enrolled. During a median of 3 years of observation, 66 subjects experienced primary infection. Of these, 77% had infectious mononucleosis, 12% had atypical symptoms, and 11% were asymptomatic. Subjects reporting deep kissing with or without coitus had the same higher risk of infection than those reporting no kissing (P < .01). Viremia was transient, but median oral shedding was 175 days. Increases were observed in numbers of NK cells and CD8(+) T-cells but not in numbers of CD4(+) T-cells during acute infection. Severity of illness correlated positively with both blood EBV load (P = .015) and CD8(+) lymphocytosis (P = .0003). CONCLUSIONS: Kissing was a significant risk for primary EBV infection. A total of 89% of infections were symptomatic, and blood viral load and CD8(+) lymphocytosis correlated with disease severity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA
Epstein, M. A., Achong, B. G., & Barr, Y. M. (1964) · The Lancet · doi:10.1016/s0140-6736(64)91524-7 · Cited by 2,778
Callan, M. F. C., Tan, L., Annels, N., Ogg, G. S., Wilson, J. D. K., O'Callaghan, C. A., Steven, N., McMichael, A. J., & Rickinson, A. B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1395 · Cited by 892 · cited 1×
“ed by others [14, 15], it is possible that a high viral load drives CD8 lymphocytosis.”
BackgroundHuman Herpesviruses: Biology, Therapy, and Immunoprophylaxis
Arvin, A. M., Campadelli‐Fiume, G., Mocarski, E. S., Moore, P. S., Roizman, B., Whitley, R. J., & Yamanishi, K. (2007) · Cited by 844
Cellular responses to viral infection in humans: lessons from Epstein–Barr virus
Hislop, A. D., Taylor, G. S., Sauce, D., & Rickinson, A. B. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141553 · Cited by 766
Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines
Miller, J. D., van der Most, R. G., Akondy, R. S., Glidewell, J. T., Albott, S., Masopust, D., Murali-Krishna, K., Mahar, P. L., Edupuganti, S., Lalor, S., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.020 · Cited by 601 · cited 1×
“studies [11] and in other viral infections [12, 13].”
BackgroundProgress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections
Odumade, O. A., Hogquist, K. A., & Balfour, H. H. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00044-10 · Cited by 458
Self-citationHeterologous immunity between viruses
Welsh, R. M., Che, J. W., Brehm, M. A., & Selin, L. K. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2010.00897.x · Cited by 292
(1985) · The Lancet · doi:10.1016/s0140-6736(85)90708-1 · Cited by 258
Doisne, J.-M., Urrutia, A., Lacabaratz-Porret, C., Goujard, C., Meyer, L., Chaix, M.-L., Sinet, M., & Venet, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2410 · Cited by 219
Crawford, D. H., Macsween, K. F., Higgins, C. D., Thomas, R., McAulay, K., Williams, H., Harrison, N., Reid, S., Conacher, M., Douglas, J., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/505400 · Cited by 209
Balfour, Jr., Holman, C. J., Hokanson, K. M., Lelonek, M. M., Giesbrecht, J. E., White, D. R., Schmeling, D. O., Webb, C., Cavert, W., Wang, D. H., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/491740 · Cited by 200
Self-citationThe immune response to primary EBV infection: a role for natural killer cells
Williams, H., McAulay, K., Macsween, K. F., Gallacher, N. J., Higgins, C. D., Harrison, N., Swerdlow, A. J., & Crawford, D. H. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05452.x · Cited by 197
The epidemiology of EBV and its association with malignant disease
Hjalgrim, H., Friborg, J., & Melbye, M. (2007) · Human Herpesviruses · doi:10.1017/cbo9780511545313.054 · Cited by 148
Silins, S. L., Sherritt, M. A., Silleri, J. M., Cross, S., Elliott, S. L., Bharadwaj, M., Le, T. T., Morrison, L. E., Khanna, R., Moss, D. J., et al. (2001) · Blood · doi:10.1182/blood.v98.13.3739 · Cited by 121
Henle, G., & Henle, W. (1967) · PubMed · Cited by 121
Contribution of Herpesvirus Specific CD8 T Cells to Anti-Viral T Cell Response in Humans
Sandalova, E., Laccabue, D., Boni, C., Tan, A. T., Fink, K., Ooi, E. E., Chua, R., Shafaeddin Schreve, B., Ferrari, C., & Bertoletti, A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001051 · Cited by 97
Primary Epstein-Barr virus infection does not erode preexisting CD8+ T cell memory in humans
Odumade, O. A., Knight, J. A., Schmeling, D. O., Masopust, D., Balfour, H. H., & Hogquist, K. A. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112401 · Cited by 77
Self-citationRiddell, L., Pinching, A. J., Hill, S., Ng, T., Arbe, E., Lapham, G. P., Ash, S., Hillman, R. J., Tchamouroff, S. E., Denning, D. W., et al. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/088922201750251981 · Cited by 53
Epstein‐Barr Virus Vaccine for the Prevention of Infectious Mononucleosis—and What Else?
Balfour, H. H. (2007) · The Journal of Infectious Diseases · doi:10.1086/523815 · Cited by 19
Self-citation
Cited by
Normalizing the environment recapitulates adult human immune traits in laboratory mice
Beura, L. K., Hamilton, S. E., Bi, K., Schenkel, J. M., Odumade, O. A., Casey, K. A., Thompson, E. A., Fraser, K. A., Rosato, P. C., Filali-Mouhim, A., et al. (2016) · Nature · doi:10.1038/nature17655 · Cited by 1,072
Self-citationEpstein-Barr virus: Biology and clinical disease
Damania, B., Kenney, S. C., & Raab-Traub, N. (2022) · Cell · doi:10.1016/j.cell.2022.08.026 · Cited by 612
The Immunology of Epstein-Barr Virus–Induced Disease
Taylor, G. S., Long, H. M., Brooks, J. M., Rickinson, A. B., & Hislop, A. D. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112326 · Cited by 602
Primary Epstein-Barr virus infection
Dunmire, S. K., Verghese, P. S., & Balfour, H. H. (2018) · Journal of Clinical Virology · doi:10.1016/j.jcv.2018.03.001 · Cited by 520
Self-citationIllness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2
Molteni, E., Sudre, C. H., Canas, L. S., Bhopal, S. S., Hughes, R. C., Antonelli, M., Murray, B., Kläser, K., Kerfoot, E., Chen, L., et al. (2021) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(21)00198-x · Cited by 421
Metadata
- Authors
- Balfour, H. H., Odumade, O. A., Schmeling, D. O., Mullan, B. D., Ed, J. A., Knight, J. A., Vezina, H. E., Thomas, W., & Hogquist, K. A.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-10-24
- Volume
- 207
- Issue
- 1
- Pages
- 80-88
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2161790138
- Cited by
- 337
- References
- 19
- FWCI
- 9.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.